Upcoming Medical Conferences in Santa Fe

45th Annual National Association for Rural Mental Health (NARMH) Conference is organized by National Association for Rural Mental Health (NARMH) and will be held from Aug 26 - 29, 2019 at La Fonda on the Plaza, Santa Fe, New Mexico, United States of America. Description: The National Association for Rural Mental Health (NARMH) Annual Conference is the premier interdisciplinary mental health event for rural families and peers, community members, clinicians, researchers, administrators and policy professionals. Now in its 45th year, the NARMH Annual Conference provides a collaborative environment for all participants across professions to learn and network on a myriad of vital issues concerning mental health practice, research, policy and advocacy in rural and remote populations.  • Preconference 1 - Strategic Doing: The Game • Preconference 2 - Join the Movement! An Intensive Hands-On Skills Training Workshop in Providing Mental Health Evaluations for Immigrants Fleeing Torture and Persecution • Preconference 3 - Peer Specialists’ Unique Role in Rural Community Health Additional details will be posted as soon as they are available.

Neurology for Primary Care Course is organized by Medical Education Resources (MER) and will be held from Sep 06 - 08, 2019 at La Fonda on the Plaza, Santa Fe, New Mexico, United States of America. This CME Conference has been approved for a maximum of 12.00 AMA PRA Category 1 Credits™. Target Audience This program is targeted to office-based primary care providers and other health professionals with updates in primary care medicine Learning Objectives Upon completion of this program, participants should be better able to: • Perform a neurological exam as well as distinguish signs of weakness and other neurological disorders • Evaluate and treat low back pain • Discuss the spectrum of sleep disorders and current management strategies • Distinguish dementia from delirium, as well as describe the neurologic changes of normal aging • Delineate the differential diagnosis and treat movement disorders • Utilize prevention and treatment strategies for cerebrovascular disorders and seizures • Review the pathophysiology of headaches, migraines, dizziness and vertigo, and discuss patient assessment and treatment options Learning Outcome To provide updates in primary care medicine to office based providers

Women's Health Conference is organized by Continuing Education Company, Inc. (CEC) and will be held from Sep 06 - 08, 2019 at Eldorado Hotel & Spa Santa Fe, Santa Fe, New Mexico, United States of America. This CME Conference has been approved for a maximum of 15 CME credits. Why Attend the Women's Health Conference in Santa Fe? • Re-energize with the perfect combination of education and relaxation with our unique half-day meeting format. Sessions are held each morning leaving you time to unwind in historic Santa Fe in the afternoons. • Learn from nationally renowned medical educators and experts in women's health. • Connect and network with women's health professionals from around the country. Earn a total of 30 CME credits with our Special CME Offer! Attend the Women's Health Conference (15 CME Credits) and you will receive a FREE online 15 credit CME course from CME365™ Unable to travel to Santa Fe? No worries! Join the LIVE conference webcast and receive the same number of credits (15) as if you attended the conference in person Santa Fe is a city full of history and culture that is sure to fascinate and inspire you. It is known as the City Different and within one visit, you will know why. Santa Fe embodies a rich history, melding Hispanic, Anglo and Native American cultures whose influences are apparent in everything from the architecture, the art, and the food. There is great diversity in the arts spanning from ancient traditional art to the most contemporary pieces, making it one of the largest and most important art markets in the country - 3rd largest in the country

24th Annual Innovations in Urologic Practice is organized by Grand Rounds in Urology (GRU) and will be held from Sep 13 - 15, 2019 at Inn and Spa At Loretto, Santa Fe, New Mexico, United States of America. Target Audience: This activity is designed for general urologists, oncologists, radiation oncologists, primary care physicians, and other healthcare providers who treat and care for urology patients. For urologists, oncologists, and radiation oncologists, this conference will focus on genitourinary cancer treatment and provide a detailed description of bladder cancer, immunotherapy, UTUC, state of the art imaging, focal therapy, and MRI for prostate cancer, and new tools and techniques for nephrectomy and treating advanced renal cell carcinoma. For general urologists and primary care physicians, there will be a focus on pelvic reconstruction and trauma, men’s health topics dealing with male infertility and sexual dysfunction, and ways to treat infectious conditions in urology. Accreditation Statement/Credit Designation: Baylor College of Medicine designates this live activity for a maximum of 11.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Description: This conference will provide a detailed review and commentary on multiple genitourinary and urologic diseases. Among the featured oncological topics are a description of bladder cancer and immunotherapies, as well as upper tract cancer management, prostate cancer, including state-of-the-art imaging, focal therapy, and MRI. Experts will also discuss new tools and techniques for nephrectomy and treating advanced renal cell carcinoma. In terms of general urological approaches, conference sessions will educate attendees on pelvic reconstruction and trauma, men’s health topics like male infertility and sexual dysfunction, and ways to diagnose and treat infections in the urology patient. Program Overview: Prostate Cancer Discussions will focus on early diagnosis and screening of prostate cancer. Specifically, our faculty will debate the role of MRI in prostate biopsies, selecting patients for active surveillance, and guiding targeted focal therapy. Both localized and advanced treatment will be subject to review and commentary. Bladder Cancer The program will emphasize case-based decision-making options for MIBC, second-line bladder cancer therapies, lymph node dissection during radical cystectomy, and immunotherapy for bladder cancer. Other Genitourinary Cancers Upper tract urothelial cancer and testis cancer management will be discussed as well as new tools and techniques for nephrectomy and treating advanced renal cell carcinoma. Men’s Health Our faculty will provide an advanced review and interactive discussion on best practices in the penile prosthesis, pelvic reconstruction and trauma, transgender surgery, hypogonadism, urethral strictures, hypospadias, nocturia, male anorgasmia, and new perspectives on treating male infertility. This section will also include updates to the new AUA guidelines on testosterone, erectile dysfunction, and urethral strictures. MIS/Flank Pain/Renal This session emphasizes and provides direction on strategies for the successful workup and management of the frustrating clinical conundrum of recurrent flank pain. Attendees will learn about the medical and surgical management of retroperitoneal fibrosis in the minimally invasive era and autosomal dominant polycystic kidney disease. Infections in Urology This session focuses on infections in the urology setting, including antimicrobial prophylaxis for transrectal prostate biopsy, management of UTIs, antimicrobial resistance, multi-drug resistant bacteria, 3D printing, VR simulators, genetic engineering, and autologous fascia for pelvic floor reconstruction. Needs Statement: This conference focuses on current controversies and innovative diagnostic and treatment strategies for some of the most common urologic problems faced by clinical urologists, oncologists, and other healthcare providers who treat patients with urologic diseases. The rapidly changing healthcare environment and pace of technological innovations in medicine require urologists, oncologists, and other healthcare providers to keep abreast of state-of-the-art diagnosis and management of urologic disease. Learning Objectives: At the conclusion of the activity, participants should be able to: • List the updated strategies for the diagnosis and management of patients with metastatic prostate cancer and apply these strategies in clinical practice • Analyze and interpret the recent literature and controversies on how to treat patients with renal cell carcinoma • List the novel therapies that are available to treat patients with overactive bladder. • Implement the use of botox and other novel therapies for overactive bladder to treat patients with overactive bladder in clinical practice • Counsel patients with metastatic prostate cancer on the appropriate treatment options available for their condition

The 27th Annual Santa Fe Symposia is organized by Boston University School of Medicine Continuing Medical Education (BUSM CME) and will be held from Oct 18 - 20, 2019 at Hilton Santa Fe Historic Plaza, Santa Fe, New Mexico, United States of America Description Boston University School of Medicine is delighted to present the 2019 Santa Fe symposia, continuing the series offered for many years by Dr. Rob Guerette. These lectures will provide psychologists, psychiatrists, psychiatric social workers, psychiatric nurses, and allied mental health professionals with an outstanding opportunity to combine a stimulating symposium with a visit to unique Santa Fe. These symposia have been designed to offer professionals an update in recent advances in several widely varied areas of mental health. In addition to the didactic lectures, there will be ample time for interchange between the participants and presenters.   Attendees will have a choice of two different programs: New Developments In The Cognitive Behavior Therapy Of Challenging Patients Donald Meichenbaum, Ph.D This three day advanced workshop that describes how Cognitive Behavior Therapy has evolved, a critique of its current effectiveness, and a detailed practical demonstration of how Constructive therapies strategies and interventions can be employed with four specific"challenging" clinical populations including:   1. Patients who have addictive disorders, including opioid abusers, with a specific focus on treatment guidelines on how to conduct an integrative treatment approach in order to achieve “lasting " changes. 2. Victimized and traumatized patients who have Complex PTSD and a variety of co-occurring disorders including prolong and complicate grief and Borderline Personality Disorder, with a specific focus on ways to incorporate evidence-based Cognitive therapy interventions to address the emotional aftermath of anxiety, depression, guilt, shame, anger and moral injuries. 3. Patients who experience anger, manifest aggression, and accompanying violence toward self and others with a specific focus on treating victims of interpersonal domestic violence. 4. Patients with Traumatic Brain Injuries focusing on ways to conduct comprehensive cognitive rehabilitation interventions.   A case conceptualization Model that informs both assessment and treatment decision-making will be presented, as well as an enumeration of the core tasks of psychotherapy that contribute to lasting changes. All attendees will receive a free copy of Dr. Meichenbaum’s recent book “Recovery Voices: Treatment Of Individuals With Addictive Disorders”   or Mindfulness and Heartfulness: Practices for Enhancing Well-Being Amy Saltzman, MD Mindfulness is paying attention here and now, with kindness and curiosity,so that we can choose our behavior. “Paying attention here and now” means doing our best to not dwell on the past, or worry or fantasize about the future; simply paying attention to what’s actually happening in this moment. And we pay attention “with kindness and curiosity.” Otherwise we are often incredibly hard on ourselves. We tend to see only where we’ve “made a mistake” or “screwed up.” Rather than judging and critiquing ourselves, with mindfulness we practice bringing an attitude of kindness and curiosity to ourselves and our experience. Finally, when we bring our kind and curious attention to our thoughts and feelings, to the sensations in our bodies, and to the people and circumstances in our lives, then we have all the information we need to “choose our behavior”—that is, respond in the moment to events in daily life. This workshop is for anyone who wants to apply these skills in their lives, and to support their patients/ clients doing the same. Together we will engage in variety of practices that will support us, and those we serve, in freeing ourselves from the inner critic, befriending difficult emotions, responding (rather than reacting) to challenging circumstances, engaging in true self-care, and offering ourselves and others kindness and compassion. Research demonstrates that for clinicians these practices decrease compassion fatigue and burnout, and increase empathy and clinical efficacy. For patients/ clients the practices decrease stress, anxiety, depression, insomnia, physical pain, resolve ineffective/ destructive habitual patterns of thinking, feeling and behaving, and increase physical, mental and emotional health, sense of purpose and meaning, and the ability to live with joy. This workshop will benefit both those with no prior experience with mindfulness and heartfulness, and those with long term practices in the field. Accreditation: Psychologists Coming Soon! Physicians Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Social Workers Coming Soon! Nurses Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Licensed Mental Health Counselors Coming Soon!

New Mexico Nurse Practitioner Council (NMNPC) 2019 Fall Conference is organized by New Mexico Nurse Practitioner Council (NMNPC) and will be held on Nov 15, 2019 at Inn & Spa at Loretto, Santa Fe, New Mexico, United States of America. Accreditation: This educational activity will be submitted to the American Association of Nurse Practitioners for approval of up to 8.0 contact hours of accredited education. Additional details will be posted as soon as they are available.

Tuberculosis: Immunity and Immune Evasion (A2) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from Jan 16 - 20, 2020 at Eldorado Hotel & Spa, Santa Fe, New Mexico, United States of America. Description Tuberculosis remains the most common fatal infectious disease worldwide due to the absence of a sufficiently effective vaccine. Two critical barriers to the development of an effective TB vaccine are the incomplete understanding of the mechanisms of protective immunity to TB, and of the mechanisms of immune evasion by M. tuberculosis. The interactions among speakers and attendees at this conference will promote collaborations between scientists with complementary expertise and that work in geographically distinct institutions, including those in high TB burden regions. This conference will present new knowledge on mechanisms of protective immunity to M. tuberculosis, and promote dialogue between immunologists and scientists, in different areas of expertise, to fill gaps in knowledge. Participants will also discuss advances in TB vaccine development and vaccine immunology. Finally, this conference will cover topics on the advances in other fields of immunology and other infectious diseases characterized by pathogen persistence which will help to inform development of effective TB vaccines. Additional details will be posted as soon as they are available.

Diabetes: Glucose Control and Beyond (J5) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from Jan 27 - 31, 2020 at Santa Fe Community Convention Center, Santa Fe, New Mexico, United States of America. Description Modern technology has created a favorable climate for the “perfect metabolic storm”. Triggered by lifestyle habits that promote overnutrition and inactivity, Westernized societies are experiencing epidemic rates of obesity and its attendant co-morbidities. Foremost among these is type 2 diabetes mellitus, which is projected to reach a global prevalence of 10% by the year 2045. This grim epidemiological forecast has inspired intense efforts to unravel the molecular mechanisms that link positive energy balance to glucose intolerance and metabolic decline. This Diabetes meeting will assemble international leaders and rising stars in diverse biomedical disciplines with common interests in understanding and combatting cardiometabolic diseases. The program showcases new insights into the molecular underpinnings of obesity-induced dysfunction of the major peripheral organs that coordinate energy flux and glucose control: skeletal and cardiac muscles, the pancreas, adipose tissue, the liver and gut. Thematic emphasis will center on nutrient sensing and signaling, inter-organ crosstalk, mechanisms of insulin resistance, mitochondrial bioenergetics, islet biology and genetics of diabetes. A major goal of the meeting is to provide a forum that encourages interactions between basic and translational scientists at all career levels to critically evaluate recent advances and current controversies. Opportunities for interdisciplinary interactions will be further enhanced by the concurrent meeting on Islet Biology: From Gene to Cell to Micro-Organ. This meeting will consider metabolism in relation to islet function, in addition to studies of islet cell plasticity and differentiation.  Additional details will be posted as soon as they are available.

Antibodies as Drugs: From B Cell Biology to New Treatments (B1) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from Feb 02 - 06, 2020 at Eldorado Hotel & Spa, Santa Fe, New Mexico, United States of America. Description Since the mid-1990s, antibodies have grown steadily into a clinically important pharmaceutical class with over 70 antibody-based drugs approved, predominantly in oncology, autoimmunity and inflammation. As the antibody drug field has expanded and matured in recent years, the field has moved from empirical strategies to deep knowledge-based, designer approaches for which understanding of mechanisms of action is critical; there has also been a trend toward increasingly specialized meetings with a narrow focus such as cancer immunotherapy, bispecifics or B cell biology.  In contrast, we are proposing a scientifically diverse program that spans a broad range of different and cutting-edge topics relevant to antibody drug development, including antibodies for infectious disease and antibody pharmacology, topics which are often under-represented at major antibody conferences. Additionally, we have chosen a diverse collection of speakers from junior investigators to seasoned researchers from a wide range of institutions in at least eight different countries. We hope and expect that this approach will stimulate ‘cross-pollination’ between disciplines that span the gamut from basic to translational to clinical sciences with the common theme of antibody drugs for the benefit of patients  Additional details will be posted as soon as they are available.

Disruptive Technologies and Opportunities for Brain Therapeutics (Q3) is organized by Keystone Symposia on Molecular and Cellular Biology and will be held from Feb 16 - 19, 2020 at Eldorado Hotel & Spa, Santa Fe, New Mexico, United States of America. Description CNS disorders represent a major unmet medical need with associated societal burden that is unsustainable due to changing demographics (e.g., aging population). Recognizing this issue, major investments in basic and translational research have been made by government and non-profit institutions world-wide. On the other hand, pharmaceutical companies and equity investors continue to view brain therapeutics as a relatively risky area of investment. This symposium aims to highlight breakthrough technologies and approaches to de-risk CNS-targeted therapies. More importantly, with the proposed agenda and speakers we aim to show that integration of cross-disciplinary knowledge and approaches has the potential to overcome the contemporary challenges of CNS drug development. A unique aspect of this symposium is to bring in scientists from a range of disciplines, who rarely participate in the same meetings, in order to create an environment that can lead to disruptive innovation. Proposed speakers will provide both general overview as well as in-depth technical presentations to engage the participants in topics ranging from disease biology-informed target selection to novel medicinal chemistry approaches, biomarkers, and clinical trial designs. Advances in technologies such as genomics, imaging and brain delivery will be highlighted throughout. In addition, the speakers proposed represent public and private sectors, young and established scientists and world-wide geography. This meeting aspires to create an interdisciplinary environment that could also spawn new collaborations that would outlast the meeting duration to address the unmet medical need of CNS disorders. Additional details will be posted as soon as they are available.